Boston Scientific Corp (NYSE:BSX) shares, rose in value, with the stock price up by 0.37% to the previous day’s close as strong demand from buyers drove the stock to $101.75.
Actively observing the price movement in the recent trading, the stock is buoying the session at $101.37, falling within a range of $101.325 and $102.1. The value of beta (5-year monthly) is 0.688 whereas the PE ratio is 74.55 over 12-month period. Referring to stock’s 52-week performance, its high was $107.17, and the low was $71.88. On the whole, BSX has fluctuated by -4.50% over the past month.
With the market capitalization of Boston Scientific Corp currently standing at about $150.53 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-23.
The stock’s technical analysis shows that the PEG ratio is about 5.30, with the price of BSX currently trading nearly -0.61% and 0.29% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.18, while the 7-day volatility ratio is showing 0.94% which for the 30-day chart, stands at 1.04%. Furthermore, Boston Scientific Corp (BSX)’s beta value is 0.69, and its average true range (ATR) is 1.90.
A comparison of Boston Scientific Corp (BSX) with its peers suggests the former has fared considerably weaker in the market. BSX showed an intraday change of 0.37% in today’s session so far, and over the past year, it grew by 33.55%%.
Data on historical trading for Boston Scientific Corp (NYSE:BSX) indicates that the trading volumes over the past 10 days have averaged 8.38 and over the past 3 months, they’ve averaged 8.21 million. According to company’s latest data on outstanding shares, there are 1.48 billion shares outstanding.
Nearly 0.40% of Boston Scientific Corp’s shares belong to company insiders and institutional investors own 92.10% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17.02 million shares as on 2025-05-30, resulting in a short ratio of 2.53. According to the data, the short interest in Boston Scientific Corp (BSX) stood at 115.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 15.71 million. The stock has risen by 13.92% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BSX stock heading into the next quarter.
